Catalyst Wire Dossier Catalyst Wire Dossier

HCR040

· Histocell, S.L.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HCR040, covering 2024-02-28 to 2024-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome [Phase 1, Phase 2]

See pricing